𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study

✍ Scribed by Henry Silver; Ahmed Nassar

Book ID
118855730
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
382 KB
Volume
31
Category
Article
ISSN
0006-3223

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Add-on mirtazapine improves depressive s
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase
✍ Viacheslav Terevnikov; Jan-Henry Stenberg; Jari Tiihonen; Marina Joffe; Mark Bur πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

Depression is common in schizophrenia and worsens its course. The role of antidepressants for schizophrenic depression remains unclear. In this study, the efficacy of add-on mirtazapine on depression in schizophrenia was explored in a subsidiary arm of a recent randomized controlled trial. Patients

Efficacy of selegiline add on therapy to
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of